Canada · Delayed Price · Currency is CAD Thiogenesis Therapeutics Statistics
Total Valuation
TSXV:TTI has a market cap or net worth of CAD 36.29 million. The enterprise value is 34.44 million.
| Market Cap | 36.29M |
| Enterprise Value | 34.44M |
Important Dates
The next estimated earnings date is Monday, November 17, 2025.
| Earnings Date | Nov 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:TTI has 51.84 million shares outstanding. The number of shares has increased by 8.65% in one year.
| Current Share Class | 51.84M |
| Shares Outstanding | 51.84M |
| Shares Change (YoY) | +8.65% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 16.90% |
| Owned by Institutions (%) | n/a |
| Float | 43.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 79.43 |
| P/TBV Ratio | 79.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.76 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.31
| Current Ratio | 1.31 |
| Quick Ratio | 1.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -195.45% and return on invested capital (ROIC) is -126.23%.
| Return on Equity (ROE) | -195.45% |
| Return on Assets (ROA) | -93.94% |
| Return on Invested Capital (ROIC) | -126.23% |
| Return on Capital Employed (ROCE) | -1,152.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.23% in the last 52 weeks. The beta is 0.65, so TSXV:TTI's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +9.23% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 0.69 |
| Relative Strength Index (RSI) | 49.54 |
| Average Volume (20 Days) | 11,266 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.26M |
| Pretax Income | -5.09M |
| Net Income | -5.09M |
| EBITDA | n/a |
| EBIT | -5.26M |
| Earnings Per Share (EPS) | -0.11 |
Balance Sheet
The company has 1.84 million in cash and n/a in debt, giving a net cash position of 1.84 million or 0.04 per share.
| Cash & Cash Equivalents | 1.84M |
| Total Debt | n/a |
| Net Cash | 1.84M |
| Net Cash Per Share | 0.04 |
| Equity (Book Value) | 456,835 |
| Book Value Per Share | 0.01 |
| Working Capital | 456,835 |
Cash Flow
| Operating Cash Flow | -3.38M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:TTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.65% |
| Shareholder Yield | -8.65% |
| Earnings Yield | -14.04% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |